EARL WILSON: Open Payments
NPI 1568455244 · BRISTOL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,576 in 113 payments from 33 companies in 2025. Trend: 2023 $2,545 · 2024 $2,835 · 2025 $2,576
Food & beverage: $2,553Speaker / faculty: $23
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $351 |
| TG Therapeutics, Inc. | 9 | $335 |
| UCB, Inc. | 9 | $304 |
| Alexion Pharmaceuticals, Inc. | 9 | $239 |
| Lundbeck LLC | 8 | $181 |
| Genentech USA, Inc. | 4 | $103 |
| PFIZER INC. | 4 | $83 |
| MDD US Operations, LLC | 4 | $83 |
| Neurocrine BioSciences, Inc. | 3 | $72 |
| Celgene Corporation | 3 | $70 |
Products named: BRIUMVI, ULTOMIRIS, Briviact, UBRELVY, QULIPTA, Nayzilam, Ocrevus Zunovo, VYEPTI.
Industry payments across TN — which companies pay providers there.
